Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)

China flag China · Delayed Price · Currency is CNY
5.17
-0.08 (-1.52%)
Mar 9, 2026, 3:04 PM CST
40.87%
Market Cap 5.46B
Revenue (ttm) 771.02M
Net Income (ttm) -107.30M
Shares Out 1.06B
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 36,823,822
Average Volume 26,836,081
Open 5.12
Previous Close 5.25
Day's Range 5.03 - 5.19
52-Week Range 2.77 - 6.14
Beta 0.28
RSI 53.82
Earnings Date Mar 19, 2026

About SHE:300006

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1999
Employees 1,019
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300006
Full Company Profile

Financial Performance

In 2024, SHE:300006's revenue was 795.60 million, a decrease of -11.17% compared to the previous year's 895.59 million. Losses were -87.80 million, 883.5% more than in 2023.

Financial Statements

News

There is no news available yet.